Blaze Bioscience Inc., Fred Hutchinson Cancer Research Center Spinoff with ZymoGenetics, Inc. (ZGEN) Vet at the Helm, Seeks to "Paint" Tumors
10/18/2011 8:12:47 AM
More...
|
Bristol-Myers Squibb Company (BMY) to Keep a Seattle Presence; to Preserve About 275 ZymoGenetics, Inc. (ZGEN) Jobs
1/26/2011 6:48:15 AM
More...
|
ZymoGenetics, Inc. (ZGEN) CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move
11/8/2010 7:48:09 AM
More...
|
Bristol-Myers Squibb Company (BMY) Third Quarter Featured Solid Operating Performance, Robust Clinical Data and the Strategic Acquisition of ZymoGenetics, Inc. (ZGEN)
10/26/2010 9:39:13 AM
More...
|
Bristol-Myers Squibb Company (BMY) Completes Acquisition of ZymoGenetics, Inc. (ZGEN)
10/13/2010 10:07:42 AM
More...
|
Bristol-Myers Squibb Company (BMY) Completes Tender Offer for ZymoGenetics, Inc. (ZGEN) with 94.9% of Shares Tendered
10/8/2010 9:49:27 AM
More...
|
Novo Nordisk A/S (NVO) Completes Divestment of ZymoGenetics, Inc. (ZGEN)
10/8/2010 9:16:05 AM
More...
|
ZymoGenetics, Inc. (ZGEN) and Bristol-Myers Squibb Company (BMY) to Present PEG-Interferon Lambda Phase 2a Interim Clinical Trial Results at AASLD 2010
10/4/2010 10:40:57 AM
More...
|
ZymoGenetics, Inc. (ZGEN) Reports Favorable Survival Data from IL-21 Phase 2a Clinical Trial in Melanoma
9/29/2010 9:55:42 AM
More...
|
ZymoGenetics, Inc. (ZGEN)'s Skin Cancer Drug Shows Promise in Study
9/29/2010 6:37:13 AM
More...
|
|